SRRK

News Scholar Rock Chief Scientific Officer Conducts Multiple Sales Throughout January 2026

14d ago

News Why Scholar Rock Holding Stock Topped the Market Today

14d ago

News Scholar Rock anticipates apitegromab approval by September 30 as FDA accepts SMA BLA with two fill-finish sites

25d ago

SEC filing SRRK Reports $480M Cash, $100M ATM Proceeds, FDA Accepts Aptegrogram BLA, $5.5B Deal, +94% YoY

26d ago

Insider trade Sale by David Hallal (Chief Executive Officer)

39d ago

Insider trade Sale by Akshay Vaishnaw (President of R&D)

39d ago

Insider trade Sale by Vikas Sinha (Chief Financial Officer)

39d ago

Insider trade Sale by Keith Woods (Chief Operating Officer)

39d ago

Insider trade Sale by Keith Woods (Chief Operating Officer)

42d ago

Insider trade Sale by Akshay Vaishnaw (President of R&D)

42d ago

Insider trade Sale by Vikas Sinha (Chief Financial Officer)

42d ago

Insider trade Sale by David Hallal (Chief Executive Officer)

42d ago

News Scholar Rock outlines 2026 apitegromab BLA resubmission and commercial launch following FDA progress

90d ago

News Scholar Rock GAAP EPS of -$0.88 beats by $0.01

91d ago

SEC filing SRRK Secures $550M Debt Facility, $367.6M Cash, Plans Apitegromab BLA Resubmission and U.S. Launch in 2026

91d ago

Insider trade Sale by David Hallal

104d ago

Insider trade Sale by Vikas Sinha

104d ago

Insider trade Sale by Keith Woods

104d ago

Insider trade Sale by Mo Qatanani

104d ago

Insider trade Sale by Caryn Parlavecchio

104d ago

Insider trade Sale by Junlin Ho

104d ago

Insider trade Sale by Mo Qatanani

104d ago

Insider trade Sale by Jing L. Marantz

104d ago

Insider trade Sale by Mo Qatanani

104d ago

News Why Scholar Rock Stock Raced 6% Higher Today

153d ago